Syngene International

At Syngene's Discovery Chemistry Operations, Lean Six Sigma projects, from same-day raw material ordering to live shipment tracking, are reducing delays and giving clients greater certainty on timelines and molecules. #Syngene #OperationalExcellence #LeanSixSigma

Our Clinical Research Associates and cross-functional teams came together for an immersive workshop on ICH E6 (R3), ALCOA+, risk-based monitoring, and inspection readiness. Building capability from within, so sponsor programmes keep moving when it matters most. #Syngene #GCP

Congratulations to Dr. Shailesh Biradar, recognised as a 'Rising Star' at the FDD Leadership Awards 2026 for his work in oral and parenteral drug product development. Our clients' molecules are in the hands of some of the most respected minds in formulation. #Syngene

Every hour saved in the lab is an hour returned to your molecule. Our new on-site solvent dispensing station at Biocon Park, Bengaluru has cut dispensing time by 80%+, helping teams move faster, reduce delays, and keep client programs on track. #Syngene #CRDMO

A big welcome to Vishwanath Krishnamurthy, joining Syngene as Head of Manufacturing Operations, Biologics. With 26+ years of experience in biologics manufacturing, he brings deep expertise in scale-up, technology transfer and operational excellence. #Biologics

We're pleased to welcome Siddharth Mittal as Managing Director and CEO of Syngene. He joins us from Biocon, bringing nearly three decades of leadership across finance, strategy and commercial operations. Welcome aboard, Siddharth. We look forward to the journey ahead. #Syngene

THANK YOU NOTE 🙏 We extend our sincere gratitude to esteemed panelists & delegates for their participation and support at our e-Conference, 'The Future of #ClinicalResearch in India: Can India Become a Global Trial Hub?' on 19 June 2026. Watch Now: indianpharmapost.com/webinar/the-fu…

Come see what we've built! Dr. Rohtash Kumar invites you inside Syngene's new ADC GMP facility. Chemistry, bioconjugation, analytical, and GMP manufacturing. All under one roof. We'd love to have you over. Book a visit: go.pardot.com/l/595011/2025-… #ADC #CDMO #Syngene

A 360° look at Booth #4907. Conversations on next-gen therapies, ADCs, and what comes next in drug development. BIO 2026 is over. The momentum isn’t. #BIO2026 #CRDMO #DrugDiscovery

The stork is staying perched at Booth #4907 at BIO 2026. Day 2 went deeper into conversations shaping biopharma. Dr. Rohtash Kumar spoke on value over volume and scaling globally while managing costs. Clear signal: partners are chosen for intent and agility. #BIO2026 #CRDMO

Syngene is now the only Indian pharma and biotech company with the JUSE-QCFI 5S certification, jointly awarded by Quality Circle Forum of India and Union of Japanese Scientists and Engineers. Two more units certified. Total now: 4. #OperationalExcellence #5S #Syngene

ADCs are changing what's possible for patients. A week since we inaugurated our new GMP bioconjugation facility for cytotoxic payloads. Syngene now offers end-to-end ADC capabilities, from discovery to GMP manufacturing. Hear from Dr. Jayashree Aiyar, CSO. #ADC #Bioconjugation

The Syngene Stork has settled in at #BIO2026. Day 1 brought sharper questions, real conversations, and a reminder of what it means to carry a molecule with care. Come say hello at Booth #4907, Hall F. #SyngeneStork #CRDMO #DrugDiscovery

400+ students. 5 government schools. From testing the pH of their own water to planting saplings, children explored health, environment, and small choices that shape the future. Somewhere in those classrooms, a future changemaker was listening. #Sustainability #CSR #Education

Your molecule is your baby. Who would you trust to carry it? In folklore, storks bring babies home. Trusted carriers of precious cargo. At #BIO2026, meet the Syngene Stork, a reflection of how we carry your molecule across discovery to manufacturing. Booth #4907. Say hello.

The CDMO question is shifting from "Who has capacity?" to "Who gets my molecule to market faster?" Dr. Rohtash Kumar, Head of CDMO at Syngene, joins key panels at #BIO2026. 📍Booth #5725 | June 23 12:00 PDT: Value Over Volume 15:55 PDT: Biologics Breakthrough #CDMO #Pharma

🚀 Ready to build a career in sterile manufacturing? 📢 Admissions Open | Limited Seats 🔗 Apply now: l1nq.com/z0ar6i3 #PharmaCareers #Biotech #LifeSciences #Freshers #SkillDevelopment #GMP

Sustainable chemistry is changing how molecules are discovered. At Syngene Hyderabad, discussions with Prof Tanmay Chatterjee highlighted how greener routes can simplify synthesis and support faster discovery. What excites you most about this shift? #GreenChemistry

What if complex chemistry could be simpler to execute? Electro-organic chemistry is enabling direct, milder routes to key ADC building blocks. Read the study: syngeneintl.com/wp-content/upl… #Electrochemistry #DrugDiscovery #ADC #ChemicalInnovation

A big moment for ADC development. Syngene has inaugurated its GMP Bioconjugation facility in Bengaluru, bringing discovery through GMP manufacturing closer together under one roof. A step forward for how complex therapies come to life. #ADC #Biopharma #CDMO #GMP